Search Results

Filter
  • 1-10 of  103 results for ""SECONDARY primary cancer""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis.

  • Authors : Lin YS; Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Yeh CC

Subjects: Aspirin/Aspirin/Aspirin/*therapeutic use ; Neoplasms, Second Primary/Neoplasms, Second Primary/Neoplasms, Second Primary/*epidemiology ; Squamous Cell Carcinoma of Head and Neck/Squamous Cell Carcinoma of Head and Neck/Squamous Cell Carcinoma of Head and Neck/*drug therapy

  • Source: PloS one [PLoS One] 2018 Aug 22; Vol. 13 (8), pp. e0199014. Date of Electronic Publication: 2018 Aug 22 (Print Publication: 2018).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus.

  • Authors : Chen ST; Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, Republic of China.; Hsueh C

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*mortality ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*physiopathology ; Neoplasms, Second Primary/Neoplasms, Second Primary/Neoplasms, Second Primary/*epidemiology

  • Source: PloS one [PLoS One] 2013; Vol. 8 (1), pp. e55179. Date of Electronic Publication: 2013 Jan 31.Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic

Record details

×
Academic Journal

Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy.

  • Authors : Peisen F; Department of Diagnostic and Interventional Radiology, Eberhard Karls University, Tuebingen University Hospital, Tuebingen, Germany.; Gerken A

Subjects: Melanoma*/Melanoma*/Melanoma*/diagnostic imaging ; Melanoma*/Melanoma*/Melanoma*/drug therapy ; Neoplasms, Second Primary*

  • Source: PloS one [PLoS One] 2024 Jan 05; Vol. 19 (1), pp. e0296253. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Early death after a diagnosis of metastatic solid cancer-raising awareness and identifying risk factors from the SEER database.

  • Authors : Globus O; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Subjects: Brain Neoplasms* ; Neoplasms, Second Primary*; Adult

  • Source: PloS one [PLoS One] 2023 Sep 26; Vol. 18 (9), pp. e0281561. Date of Electronic Publication: 2023 Sep 26 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

The Brazilian National Oral Health Policy and oral cancer mortality trends: An autoregressive integrated moving average (ARIMA) model.

Subjects: Mouth Neoplasms* ; Neoplasms, Second Primary*; Humans

  • Source: PloS one [PLoS One] 2023 Sep 21; Vol. 18 (9), pp. e0291609. Date of Electronic Publication: 2023 Sep 21 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
  • 1-10 of  103 results for ""SECONDARY primary cancer""